Implementing new health interventions in developing countries: why do we lose a decade or more?

BMC Public Health

Table 6 Relative rates of beginning implementation by intervention and country income (Cox proportional hazard)

	Rate of beginning implementation	95% confidence interval
*Haemophilus influenzae* type B vaccine	0.81	(0.60-1.08)
Rotavirus vaccine	1.99	(0.85-4.66)
Pneumococcal vaccine	1.18	(0.70-1.98)
Insecticide-treated mosquito nets	0.96	(0.68-1.34)
Rapid diagnostic test	0.54	(0.33-0.88)
Artemisinin-based combination therapy	2.41	(1.38-4.21)
Low-income	0.51	(0.40-0.64)
Lower-middle-income	0.56	(0.44-0.70)
Upper-middle-income	0.52	(0.41-0.67)

Legend.
Rates of beginning implementation are calculated relative to the rate of beginning HepB implementation in high income countries in the absence of any of the facilitating milestones. All likelihood ratio statistics (interventions having 6 degrees of freedom and income groups having 3) testing these effects were highly significant, with P < 0.001.

ISSN: 1471-2458